Novartis AG vs Shopify Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Shopify Inc. trades at $122.92 (market cap $161.53B). The key difference: Novartis AG is the larger of the two by market cap, and Novartis AG pays a 3.17% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals.
| NVS | SHOP | |
|---|---|---|
Market Cap | $290.25B | $161.53B |
Sector | Health | Technology |
52-Week High | $168.62 | $179.01 |
52-Week Low | $113.50 | $95.40 |
Enterprise Value | $330.27B | $155.97B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →